VicPlas International Ltd. (SG:569)
SGX:569
569 Stock Chart & Stats
S$0.09
<S$0.01(2.13%)
At close: 4:00 PM EST
S$0.09
<S$0.01(2.13%)
Day’s Range― - ―
52-Week RangeS$0.07 - S$0.10
Previous CloseN/A
Volume100.00
Average Volume (3M)97.25K
Market Cap
S$44.46M
Enterprise ValueS$80.86M
Total Cash (Recent Filing)S$4.71M
Total Debt (Recent Filing)S$41.11M
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Sep 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding511,537,700
10 Day Avg. Volume66,350
30 Day Avg. Volume97,253
Financial Highlights & Ratios
PEG Ratio-0.28
Price to Book (P/B)0.65
Price to Sales (P/S)0.39
P/FCF Ratio-7.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Revenue StreamsVicPlas’s dual-segment model (piping systems and medical devices) provides durable revenue diversification across construction and healthcare end markets. Structural demand in both sectors reduces single-market dependence and supports resilience if one end market weakens over the next several months.
Top-line RecoveryA marked revenue rebound coupled with sustained gross margins indicates product pricing power and recovered demand. This top-line momentum improves the company’s ability to scale fixed costs and absorb shocks, making near-term revenue growth a more reliable foundation for margin recovery over 2–6 months.
Equity Cushion On Balance SheetDespite higher leverage, the company’s sizeable equity base offers a buffer to absorb continued losses or cycling cash flows. This capital cushion increases resilience, supports creditor confidence, and gives management runway to execute operational fixes without immediate solvency pressure.
Bears Say
Rising LeverageA rising debt-to-equity ratio signals increased reliance on external financing and higher fixed obligations. Over the medium term this constrains financial flexibility, raises interest burden risk, and reduces capacity for strategic investment if cash generation does not improve.
Weak Cash GenerationSharp deterioration in operating cash flow and consecutive negative free cash flow undermine the company’s ability to fund capex, service debt, or rebuild buffers organically. Persistent weak cash conversion forces reliance on external funding and increases execution risk for restructuring efforts.
Shift To Net LossesA transition from multi-year profitability to recurring losses erodes retained earnings and return metrics. Unless structural cost or mix issues are addressed, continued losses will limit reinvestment, weaken ROE, and could force more aggressive financing or cost cuts that impair growth.
VicPlas International Ltd. News
569 FAQ
What was VicPlas International Ltd.’s price range in the past 12 months?
VicPlas International Ltd. lowest share price was S$0.07 and its highest was S$0.10 in the past 12 months.
What is VicPlas International Ltd.’s market cap?
VicPlas International Ltd.’s market cap is S$44.46M.
When is VicPlas International Ltd.’s upcoming earnings report date?
VicPlas International Ltd.’s upcoming earnings report date is Sep 28, 2026 which is in 180 days.
How were VicPlas International Ltd.’s earnings last quarter?
VicPlas International Ltd. released its earnings results on Mar 13, 2026. The company reported -S$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.007.
Is VicPlas International Ltd. overvalued?
According to Wall Street analysts VicPlas International Ltd.’s price is currently Overvalued.
Does VicPlas International Ltd. pay dividends?
VicPlas International Ltd. does not currently pay dividends.
What is VicPlas International Ltd.’s EPS estimate?
VicPlas International Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VicPlas International Ltd. have?
VicPlas International Ltd. has 511,537,700 shares outstanding.
What happened to VicPlas International Ltd.’s price movement after its last earnings report?
VicPlas International Ltd. reported an EPS of -S$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.124%.
Which hedge fund is a major shareholder of VicPlas International Ltd.?
Currently, no hedge funds are holding shares in SG:569
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VicPlas International Ltd.
Vicplas International Ltd, an investment holding company, engages in the medical devices, and pipes and pipe fittings businesses in Singapore, Malaysia, the People's Republic of China, and the United Kingdom. The company manufactures, trades, and distributes piping systems for various industries, including waste and potable water systems for residential homes, schools, and commercial and industrial buildings; underground electrical and internal building wire piping systems; and data and signal line piping systems by telecommunications companies. It also designs, develops, manufactures, and assembles sterile and non-sterile medical devices; and provides project design and engineering services. Vicplas International Ltd was founded in 1993 and is headquartered in Singapore. Vicplas International Ltd is a subsidiary of Venner Capital S.A.
Technical Analysis
HC Surgical Specialists Ltd
―
Medtecs International Corporation Ltd.
―
Biolidics Ltd.
―
Singapore Paincare Holdings Limited
―
Alliance Healthcare Group Ltd.
―